If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriad Regulatory News (TRD)

Share Price Information for Triad (TRD)

Share Price is delayed by 15 minutes
Get Live Data
355.00    40.00 (12.12%)
Bid:
350.00
Ask:
360.00
Spread: 10.00 (2.857%)
Market Cap: £64.49m
TRD Live PriceLast checked at - London Stock Exchange

Intraday Triad Share Chart

Director/PDMR Shareholding

19 Mar 2025 16:00

RNS Number : 3447B
Triad Group Plc
19 March 2025
 

Triad Group Plc

("Triad" or "the Company")

Notification of Transactions by Person Discharging Managerial Responsibilities

The Company announces that it has been informed that, on 17 March 2025, Alison Lander (Non-Executive Director) has in order to effect a "Bed and ISA" transaction, sold 5,634 ordinary shares of £0.01 each ("Ordinary Shares") at a price of 350.00 pence per Ordinary Share and then repurchased into her Individual Savings Account (ISA), 5,592 Ordinary Shares at a price of 350.80 pence per Ordinary Share.

Following the completion of these transactions her ultimate beneficial ownership is changed to 177,248 Ordinary Shares in total, representing still 1.06% of the Company's total voting rights.

The Notification of Dealing Form for the above transactions, provided in accordance with the requirements of Article 19 of UK MAR, may be found below.

1.

Details of PDMR / person closely associated with them

a)

Name

Alison Lander

2.

Reason for the notification

a)

Position / status

Non-Executive Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Triad Group Plc

b)

LEI

213800MDNBFVEQEN1G84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary shares of £0.01 each

 

 

ISIN: GB0009035741

b)

Nature of the transaction

On market sale of Ordinary Shares and immediate repurchase by way of Bed and ISA arrangement

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£3.5000 (sale)

£3.5800 (purchase)

5,634

5,592

d)

Aggregated information

-Aggregated sale

-Aggregated purchase

 

5,634 - price of £3.5000

5,592 - price of £3.5800

e)

Date of the transaction

17 March 2025

f)

Place of the transaction

LONDON STOCK EXCHANGE XLON

 

For further information, please contact:

Triad Group Plc

James McDonald

Finance Director and Company Secretary

01908 278 450

 

Zeus Capital Limited

Alexandra Campbell-Harris

Tel: 020 7614 5900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUKVORVWUOAAR
Date   Source Headline
17th Feb 20212:01 pmRNSPrice Monitoring Extension
29th Jan 20214:00 pmRNSTotal Voting Rights
27th Jan 202111:05 amRNSSecond Price Monitoring Extn
27th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 20212:00 pmRNSTrading Statement
13th Jan 20214:00 pmRNSDirector/PDMR Shareholding
8th Jan 202111:06 amRNSSecond Price Monitoring Extn
8th Jan 202111:01 amRNSPrice Monitoring Extension
7th Jan 20214:00 pmRNSStatement re Share Price Movement
7th Jan 202111:05 amRNSSecond Price Monitoring Extn
7th Jan 202111:00 amRNSPrice Monitoring Extension
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
5th Jan 20214:40 pmRNSSecond Price Monitoring Extn
5th Jan 20214:35 pmRNSPrice Monitoring Extension
5th Jan 20212:05 pmRNSSecond Price Monitoring Extn
5th Jan 20212:00 pmRNSPrice Monitoring Extension
5th Jan 202111:00 amRNSPrice Monitoring Extension
5th Jan 20219:06 amRNSSecond Price Monitoring Extn
5th Jan 20219:00 amRNSPrice Monitoring Extension
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
27th Nov 20209:05 amRNSSecond Price Monitoring Extn
27th Nov 20209:00 amRNSPrice Monitoring Extension
27th Nov 20207:00 amRNSHalf-year Report
24th Sep 20204:30 pmRNSResult of AGM
14th Sep 20207:00 amRNSBlock listing Interim Review
9th Sep 20204:00 pmRNSTotal Voting Rights
28th Aug 20202:00 pmRNSNotice of AGM
18th Jun 20207:00 amRNSFinal Results
17th Jun 202011:16 amRNSDirectorate Change
16th Mar 202010:24 amRNSBlock listing Interim Review
2nd Mar 20204:00 pmRNSChange of Company Secretary
2nd Mar 20201:16 pmRNSTotal Voting Rights
20th Feb 20203:00 pmRNSPCA Share Purchase
3rd Feb 202012:20 pmRNSDirector/PCA Dealings
9th Jan 20207:00 amRNSFramework Partnership with Stratis Group Ltd
20th Dec 20197:00 amRNSDirectorate Change
20th Dec 20197:00 amRNSHalf-year Report
6th Dec 20193:00 pmRNSTotal Voting Rights
23rd Sep 20192:34 pmRNSDirectorate Resignation
13th Sep 20193:09 pmRNSBlock listing Interim Review
14th Aug 20192:47 pmRNSResult of AGM
5th Aug 20192:11 pmRNSDirectorate Resignation
18th Jul 201911:39 amRNSNotice of AGM
10th Jun 20199:45 amRNSCorrection to dividend payment date
10th Jun 20197:00 amRNSFinal Results
14th Mar 20194:16 pmRNSBlock listing Interim Review
1st Mar 20193:25 pmRNSStatement re Recent High Court Hearing
1st Feb 20191:17 pmRNSDirector/PDMR Shareholding and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.